ONBOARDx™FLOQ® SARS-CoV-2 Variant Swab Kit / Verification Panel 20% off!
By Pavel Zhelev | March 31, 2021
Microbix Announces Annual and Special Meeting Voting Results
By Pavel Zhelev | March 31, 2021
Virtual AGM on March 30, 2021
By Pavel Zhelev | March 30, 2021
AGM Presentation – March 2021
By Pavel Zhelev | March 29, 2021
Microbix & Seegene Canada Form COVID-Variant Collaboration
By Pavel Zhelev | March 15, 2021
Microbix Antigen-test QAPs Now Available For Clinical Use
By Pavel Zhelev | March 11, 2021
Microbix Announces Issuance of Stock Options
By Pavel Zhelev | February 18, 2021
Microbix Announces Quality Products Distribution Agreement
By Pavel Zhelev | February 16, 2021
Microbix Reports Results for Q1 Fiscal 2021
By Pavel Zhelev | February 11, 2021
Microbix Announces Material First Sales of Viral Transport Medium
By Pavel Zhelev | February 9, 2021
Microbix Viral Transport Medium Now Available
By Pavel Zhelev | January 28, 2021
Microbix & Copan Italia Execute Strategic Agreement
By Pavel Zhelev | December 21, 2020
Microbix Reports Results for Fiscal 2020
By Pavel Zhelev | December 18, 2020
Microbix Presenting Product Results at AACC
By Pavel Zhelev | December 15, 2020
Microbix Announces Addition to Board of Directors
By Pavel Zhelev | December 7, 2020